US Patent Issued to CAMBRIDGE ALLERGY on June 2 for "Allergenic protein formulations for immunotherapy" (British Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,762, issued on June 2, was assigned to CAMBRIDGE ALLERGY Ltd. (Cambridge, Great Britain).

"Allergenic protein formulations for immunotherapy" was invented by Robert Neil Ward (Deeside, Great Britain), Ryan John Anthony Wilson (Deeside, Great Britain) and Michael John Frodsham (Deeside, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to an oral immunotherapy (OIT) composition comprising granules that contain an allergenic protein, such as peanut protein, along with a humectant, such as trehalose, and a binder, such as hypromellose. The composition may further comprise a filler, such as mannitol and a lubricant, such...